Voyager Therapeutics Inc
NASDAQ:VYGR

Watchlist Manager
Voyager Therapeutics Inc Logo
Voyager Therapeutics Inc
NASDAQ:VYGR
Watchlist
Price: 4.39 USD -0.45% Market Closed
Market Cap: 244.1m USD

Wall Street
Price Targets

VYGR Price Targets Summary
Voyager Therapeutics Inc

Wall Street analysts forecast VYGR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VYGR is 15.3 USD with a low forecast of 8.08 USD and a high forecast of 26.25 USD.

Lowest
Price Target
8.08 USD
84% Upside
Average
Price Target
15.3 USD
249% Upside
Highest
Price Target
26.25 USD
498% Upside
Voyager Therapeutics Inc Competitors:
Price Targets
RYTM
Rhythm Pharmaceuticals Inc
13% Upside
145020
Hugel Inc
72% Upside
ZYME
Zymeworks Inc
38% Upside
600201
Jinyu Bio-Technology Co Ltd
42% Downside
ABNX
Abionyx Pharma SA
213% Upside
PTCT
PTC Therapeutics Inc
10% Upside
6160
Beigene Ltd
35% Upside
CRSP
CRISPR Therapeutics AG
41% Upside

Revenue
Forecast

Revenue Estimate
Voyager Therapeutics Inc

The compound annual growth rate of Voyager Therapeutics Inc's revenue for the next 4 years is -1%.

N/A
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Voyager Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Voyager Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VYGR's stock price target?
Price Target
15.3 USD

According to Wall Street analysts, the average 1-year price target for VYGR is 15.3 USD with a low forecast of 8.08 USD and a high forecast of 26.25 USD.

What is Voyager Therapeutics Inc's Revenue forecast?
Projected CAGR
-1%

The compound annual growth rate of Voyager Therapeutics Inc's revenue for the next 4 years is -1%.

Back to Top